Patents by Inventor André Jomard

André Jomard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SCREENING FOR MODULATORS OF CES1 AND/OR CES3 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
    Publication number: 20110150774
    Abstract: An in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea, includes determining the ability of a compound to modulate the expression or the activity of the carboxylesterase 1 (CES1) and/or carboxylesterase 3 (CES3) proteins.
    Type: Application
    Filed: May 7, 2009
    Publication date: June 23, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Michel Rivier, Séverine Corvaisier, André Jomard
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7807669
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: October 5, 2010
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • TOPICAL APPLICATION OF TRAVOPROST FOR COMBATING HAIR LOSS
    Publication number: 20100190853
    Abstract: Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.
    Type: Application
    Filed: February 23, 2010
    Publication date: July 29, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Sandrine Rethore, Carine Rosignoli, André Jomard, Johannes Voegel
  • TOPICAL APPLICATION OF FLUOCINOLONE ACETONIDE FOR DEPIGMENTATION OF THE SKIN
    Publication number: 20100124538
    Abstract: Topically applicable compositions useful for the depigmentation of the skin contain a fluocinolone acetonide depigmenting agent, at a concentration of from 0.0001% to 0.02% by weight, of the total weight of the composition, formulated into physiologically acceptable carrier therefor.
    Type: Application
    Filed: August 14, 2009
    Publication date: May 20, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Isabelle Pelisson, André Jomard
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7582663
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: September 17, 2007
    Date of Patent: September 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • DERMATOLOGICAL COMPOSITIONS COMPRISING HYDROQUINONE, FLUOCINOLONE ACETONIDE AND TRETINOIN FOR TREATING THE HYPERPIGMENTATION OF PATHOLOGICAL SCARS
    Publication number: 20090111783
    Abstract: Dermatological medicament compositions contain a combination of hydroquinone, fluocinolone acetonide and tretinoin and are useful for the treatment of the hyperpigmentation of pathological scars, namely, hypertrophic scars and keloidal scars.
    Type: Application
    Filed: October 24, 2008
    Publication date: April 30, 2009
    Applicant: GALDERMA S.A.
    Inventors: Isabelle PELISSON, Andre Jomard
  • NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPARY TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
    Publication number: 20090062340
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: November 6, 2008
    Publication date: March 5, 2009
    Applicant: Galderma Research & Development
    Inventors: LAURENCE CLARY, CLAIRE BOUIX-PETER, MICHEL RIVIER, PASCAL COLLETTE, ANDRE JOMARD
  • Treating skin hyperpigmentation with dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin
    Publication number: 20090018108
    Abstract: Hyperpigmentary skin disorders, notably those associated with psoriasis or eczema, are prevented/treated by administering to individuals in need of such treatment, thus effective amounts of medicaments containing a combination of fluocinolone acetonide, hydroquinone and tretinoin, formulated into a physiologically acceptable medium therefor.
    Type: Application
    Filed: June 11, 2008
    Publication date: January 15, 2009
    Applicant: GALDERMA S.A.
    Inventors: Isabelle Pelisson, Andre Jomard
  • Biaromatic compounds which activate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7452878
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: November 18, 2008
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Skin depigmenting compositions comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent
    Publication number: 20080219936
    Abstract: Depigmenting compositions for the skin, comprise, formulated into a physiologically acceptable medium, adapalene, at least one depigmenting agent and at least one anti-inflammatory agent, and to the pharmaceutical/cosmetic applications thereof.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 11, 2008
    Applicant: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Isabelle Pelisson, Andre Jomard
  • Pharmaceutical Or Cosmetic Composition Comprising Mequinol And At Least One Depigmenting Agent
    Publication number: 20080159969
    Abstract: The invention relates to a pharmaceutical or cosmetic composition comprising, in a physiologically acceptable medium, mequinol and at least one depigmenting agent, and to the use thereof.
    Type: Application
    Filed: May 13, 2005
    Publication date: July 3, 2008
    Applicant: Galderma Research & Development, S.N.C.
    Inventors: Isabelle Pelisson, Andre Jomard, Cecile Cousin
  • Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20080070957
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: September 17, 2007
    Publication date: March 20, 2008
    Applicant: Galderma Research & Development, S.N.C.
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Vitamin D analogues
    Patent number: 7312249
    Abstract: Novel biaromatic vitamin D analogues have the general formula (I): and are suited for a wide variety of pharmaceutical applications, whether in human or veterinary medicine, and also for cosmetic applications.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: December 25, 2007
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Etienne Thoreau, Johannes Voegel, Andre Jomard
  • Polycyclic compounds which modulate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7307078
    Abstract: Novel polycyclic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: December 11, 2007
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Pascal Collette, Michel Rivier, Andre Jomard
  • Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7285568
    Abstract: Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: October 23, 2007
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Claire Bouix-Peter, Michel Rivier, Pascal Collette, Andre Jomard
  • Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20070093487
    Abstract: Novel polycyclic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: September 20, 2006
    Publication date: April 26, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Pascal Collette, Michel Rivier, Andre Jomard
  • Cosmetic/dermatological applications of PPAR receptor activators
    Publication number: 20070065471
    Abstract: Cosmetic/pharmaceutical compositions useful for regulating the size of sebaceous glands and, in particular, for inhibiting sebum production, or for treating pathologies entailing an overproduction of sebum, or for treating greasy skin and/or a scalp prone to dandruff, contain thus effective amounts of at least one activator of PPAR type receptors.
    Type: Application
    Filed: June 1, 2006
    Publication date: March 22, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT S.N.C.
    Inventors: Andre Jomard, Michel Rivier
  • Polycyclic compounds which modulate PPAR? type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7125869
    Abstract: Novel polycyclic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: October 24, 2006
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Pascal Collette, Michel Rivier, Andre Jomard
  • Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060009484
    Abstract: Novel polycyclic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: June 10, 2005
    Publication date: January 12, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Laurence Clary, Pascal Collette, Michel Rivier, Andre Jomard
  • Pharmaceutical compositions comprising calcitriol and a clobetasol propionate
    Publication number: 20060009426
    Abstract: Topically applicable pharmaceutical gel, cream, lotion, solution or ointment compositions contain synergistically effective amounts of a) calcitriol and b) clobetasol propionate, formulated into a topically applicable, pharmaceutically acceptable medium therefor, and are useful for the treatment of such dermatological afflictions or conditions as psoriasis, atopic dermatitis, contact dermatitis and seborrhoeic dermatitis.
    Type: Application
    Filed: June 17, 2005
    Publication date: January 12, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Andre Jomard, Olivier Roye